Invention Grant
US07956047B2 Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation
有权
硫酸软骨素E（CS-E）用于治疗与胶原纤维形成有关的疾病或病症
- Patent Title: Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation
- Patent Title (中): 硫酸软骨素E（CS-E）用于治疗与胶原纤维形成有关的疾病或病症
-
Application No.: US11587675Application Date: 2005-04-26
-
Publication No.: US07956047B2Publication Date: 2011-06-07
- Inventor: Anders Aspberg , Dick Heinegård , Anna Johnson , Alexander Kvist
- Applicant: Anders Aspberg , Dick Heinegård , Anna Johnson , Alexander Kvist
- Applicant Address: SE Gothenburg
- Assignee: AnaMar AB
- Current Assignee: AnaMar AB
- Current Assignee Address: SE Gothenburg
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: SE0401069 20040426
- International Application: PCT/SE2005/000599 WO 20050426
- International Announcement: WO2005/102362 WO 20051103
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/715 ; A61K31/737 ; C07H1/00 ; A61P19/00
Abstract:
The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds can be administrated either by oral, topical, injectable or by any other suitable route.
Public/Granted literature
Information query
IPC分类:
